In clinical practice, psychotic symptoms and substance use often overlap

This requires a thorough and nuanced assessment process. Distinguishing between drug-linked symptoms and other mental health conditions is essential for providing the most appropriate level of care and support.

This session provides a clinically rigorous overview of psychosis risk within the modern drug environment. Participants will explore DSM-5-TR criteria and differential diagnosis considerations that help clarify the clinical picture. We will discuss high-risk populations and identify clinical markers that support thoughtful assessment, ensuring treatment planning is targeted and effective for those experiencing these complex symptoms.

What you’ll learn

• How to apply DSM rules to differentiate drug-linked psychosis from other mental health conditions
• Identification of disorders and populations at the highest risk for drug-induced psychosis
• Mastery of differential diagnosis to prevent clinical misidentification
• Key clinical “red flags” that influence diagnosis and treatment selection
• Factors that support more effective, targeted treatment interventions

Register to gain applied insight, 1.5 free CEUs*, and a stronger framework for understanding and supporting youth resilience and wellbeing

Presenters: Bethany Nold, LCPC – Program Development Manager at Camber Mental Health & Michelle Leone, RN Senior Vice President at St. Louis Children’s and Camber Mental Health Youth Mental Health Care

PS: Can’t attend live? Register anyway, and we’ll send you the recording.

*You will receive 1.5 continuing education credits (CEUs) for each webinar you attend live. CEUs cannot be awarded for watching recordings.

These CEUs are approved by the Kansas and Missouri State Committees of Social Workers and may be used by professionals who recognize State Committee for Social Worker-approved CEUs.